Home > Journals > Minerva Ortopedica e Traumatologica > Past Issues > Minerva Ortopedica e Traumatologica 2017 December;68(4) > Minerva Ortopedica e Traumatologica 2017 December;68(4):207-15

CURRENT ISSUE
 

JOURNAL TOOLS

eTOC
To subscribe PROMO
Submit an article
Recommend to your librarian
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

 

REVIEW   

Minerva Ortopedica e Traumatologica 2017 December;68(4):207-15

DOI: 10.23736/S0394-3410.17.03842-5

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

Management of periprosthetic joint infection

Rahul GOEL, Majd TARABICHI, Ibrahim AZBOY, Michael M. KHEIR, Javad PARVIZI

Department of Orthopedic Surgery, The Rothman Institute at Thomas Jefferson University, Philadelphia, PA, USA


PDF


Periprosthetic joint infection (PJI) is a complication of great consequence following total joint arthroplasty, placing a tremendous burden on physicians and patients alike. Given the frequency at which these procedures are performed, as well as the ever-growing demand for them, the prevalence of disease is similarly expected to increase. Current trends in the literature demonstrate an increasing financial burden imposed by PJI, as well as the increasing incidence of drug-resistant organisms as a cause of PJI, further compounding the difficulty of management of this complication. The aim of this review was to provide the latest updates in the prevention, treatment and diagnosis of PJI, with a view to identifying areas in need of further research.


KEY WORDS: Joints - Infection - Arthroplasty, replacement, hip - Arthroplasty, replacement, knee

top of page